Zy. Liu et al., REVERSING EFFECT OF ,5'6'-DIMETHYLENEDIOXYBIPHYNYL1-2,2'-DICARBOXYLATE (DDB) ON THE PHENOTYPES OF HUMAN HEPATOCARCINOMA CELLS LINE, Cancer letters, 108(1), 1996, pp. 67-72
When human Bel-7402 hepatocarcinoma cell line grew in a medium contain
ing 10(-4) M dimethyl-4,4'-dimethoxy-5,6,5',6'- dimethylenedioxybiphyn
yl-2,2'-dicarboxyl (DDB), the secretion of alpha-fetoprotein (AFP) was
significantly lower than the control cells, whereas the albumin (ALB)
secretion was markedly higher. The activity of gamma-glutamultranspep
eidase (gamma-GT) in DDB-treated cells markedly decreased in compariso
n with the control cells. On the contrary, the activity of tyrosine-al
pha-ketoglutarate transaminase (TAT) was higher in DDB-treated cells t
han in control cells. DDB (10(-4) M) could significantly increase the
content of cAMP in Bel-7402 cells, and also enhance the expression of
anti-oncogene p53. The results suggest that DDB has reversing effects
on the phenotypes of the human Bel-7402 hepatocarcinoma cell line.